Alexander A. Ozerov, Lyudmila V. Naumenko, Alyona S. Taran, Dmitry S. Yakovlev, Alina M. Chebanko, Maria S. Pshenichnikova, Nadezhda M. Shcherbakova, G. N. Solodunova, D. Merezhkina, Александр A. Spasov
{"title":"Synthesis of new heterocyclic derivatives (benzodioxane-2-yl)methanol and their effect on rat intraocular pressure","authors":"Alexander A. Ozerov, Lyudmila V. Naumenko, Alyona S. Taran, Dmitry S. Yakovlev, Alina M. Chebanko, Maria S. Pshenichnikova, Nadezhda M. Shcherbakova, G. N. Solodunova, D. Merezhkina, Александр A. Spasov","doi":"10.19163/1994-9480-2023-20-4-127-135","DOIUrl":null,"url":null,"abstract":"Objective: Synthesis of new compounds, melatonin isosters, and study of their ability to reduce intraocular pressure. \nMaterials and methods: Based on the previously made forecast and on the similarity with the selected compounds, the synthesis of new compounds was carried out – melatonin isosters having a 2,3-dihydro-1,4-benzodioxin cycle connected by a linker of various chemical structure with a nitrogen-containing heterocyclic core. The structure of the synthesized compounds was proved by 1H- and 13C- NMR spectroscopy, purity and individuality – by chromatographic methods. Intraocular pressure in laboratory animals was measured using a contact veterinary tonometer Tonovet (Finland). Cytotoxicity was assessed using MTT test on normal rat skin fibroblasts. \nResults: Derivatives (benzodioxane-2-yl)methanol reduced the level of IOP in varying degrees of severity. The VMA-22-37 compound showed the greatest activity. With topical application of a 0.4% solution, the compound reduced the intraocular pressure of intact rats by 26.6%, while not affecting the control eye. This compound also has low cytotoxicity. \nConclusion: Derivatives (benzodioxane-2-yl)methanol is promising for the search for compounds capable of reducing increased intraocular pressure.","PeriodicalId":377653,"journal":{"name":"Journal of Volgograd State Medical University","volume":"166 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Volgograd State Medical University","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19163/1994-9480-2023-20-4-127-135","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Synthesis of new compounds, melatonin isosters, and study of their ability to reduce intraocular pressure.
Materials and methods: Based on the previously made forecast and on the similarity with the selected compounds, the synthesis of new compounds was carried out – melatonin isosters having a 2,3-dihydro-1,4-benzodioxin cycle connected by a linker of various chemical structure with a nitrogen-containing heterocyclic core. The structure of the synthesized compounds was proved by 1H- and 13C- NMR spectroscopy, purity and individuality – by chromatographic methods. Intraocular pressure in laboratory animals was measured using a contact veterinary tonometer Tonovet (Finland). Cytotoxicity was assessed using MTT test on normal rat skin fibroblasts.
Results: Derivatives (benzodioxane-2-yl)methanol reduced the level of IOP in varying degrees of severity. The VMA-22-37 compound showed the greatest activity. With topical application of a 0.4% solution, the compound reduced the intraocular pressure of intact rats by 26.6%, while not affecting the control eye. This compound also has low cytotoxicity.
Conclusion: Derivatives (benzodioxane-2-yl)methanol is promising for the search for compounds capable of reducing increased intraocular pressure.